Safety of sildenafil in premature infants with severe bronchopulmonary dysplasia (SILDI-SAFE): a multicenter, randomized, placebo-controlled, sequential dose-escalating, double-masked, safety study
Abstract Background Pulmonary hypertension is a deadly complication of bronchopulmonary dysplasia, the most common pulmonary morbidity of prematurity. Despite these catastrophic consequences, no evidence-based therapies are available for the prevention of pulmonary hypertension in this population. S...
Saved in:
Main Authors: | Simone Schneider (Author), Mary Bailey (Author), Tracy Spears (Author), Charles R. Esther (Author), Matthew M. Laughon (Author), Christoph P. Hornik (Author), Wesley Jackson (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2020-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy of Sildenafil in Infants with Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension
by: Kacie Dillon, et al.
Published: (2023) -
Sildenafil Use in the Treatment of Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Case Series
by: Amna Qasim, et al.
Published: (2018) -
The efficacy and safety of Montelukast sodium in the prevention of bronchopulmonary dysplasia
by: Sang Bum Kim, et al.
Published: (2015) -
Bronchopulmonary Dysplasia: An Overview
by: Gisondo CM, et al.
Published: (2020) -
Considerations for de-escalating universal masking in healthcare centers
by: Caroline Landelle, et al.
Published: (2023)